Trial Evaluating Zuranolone for Postpartum Depression Meets All Endpoints
A phase 3 study evaluating zuranolone in women with postpartum depression met its primary and key secondary endpoints, according to Sage Therapeutics and Biogen. Zuranolone is an investigational oral neuroactive steroid GABA-A receptor positive allosteric…